{"id":21682,"date":"2025-07-09T13:27:35","date_gmt":"2025-07-09T11:27:35","guid":{"rendered":"https:\/\/www.m-q.ch\/?p=21682"},"modified":"2025-07-09T13:27:35","modified_gmt":"2025-07-09T11:27:35","slug":"ten-swiss-medtech-startups-selected-for-us-expansion","status":"publish","type":"post","link":"https:\/\/www.m-q.ch\/en\/ten-swiss-medtech-startups-selected-for-us-expansion\/","title":{"rendered":"Ten Swiss medtech start-ups selected for US expansion"},"content":{"rendered":"
\"\"
Ten medtech start-ups will be able to present themselves to various investors in the USA from September 28. (Image: Venture Leaders)<\/figcaption><\/figure>\n

Venturelab has been putting together the Swiss national start-up team since 2006. As part of the Venture Leaders Roadshows, the entrepreneurs meet investors, industry experts and potential customers in leading global technology centers such as Silicon Valley, Boston, Asia, Barcelona, Munich and London. The Venture Leaders Medtech 2025 program is supported by EPFL, ETH Zurich, Hansj\u00f6rg Wyss, Helbling Technik, the Health Innovation Hub Aargau, Kellerhals Carrard, the Canton of Vaud and Vischer.<\/p>\n

Attracting international attention<\/h3>\n

After a competitive selection process that reviewed over 70 applications, a panel of investors and industry experts selected ten startups to participate in the upcoming roadshow in Boston - one of the world's leading centers for healthcare innovation. The week-long program will give participants the opportunity to connect with company representatives, potential partners and investors and advance their US market entry strategy.<\/p>\n

The selected Swiss medtech startups are receiving international attention - and for good reason: they address challenges such as smart implants, AI-assisted diagnostics, neonatal nutrition and non-invasive monitoring. \"These innovations are not only impressive - they have the potential to change medical technology worldwide,\" says Stefan Steiner, Co-Managing Director of Venturelab.<\/p>\n

This year's Venture Leaders Medtech participants join a remarkable group of previous attendees - including Lunaphore Technologies (acquired by Bio-Techne), Virtamed, Credentis (acquired by vVardis), Stimit (acquired by Dr\u00e4ger), CUTISS, Distalmotion, MindMaze, Positrigo and Volumina Medical. \"The organization of the program was exceptional, and the quality of the meetings exceeded all my expectations,\" says Pablo Lara, co-founder of OncoSwab and former Venture Leader Medtech 2024 participant. \"I was so impressed that I even postponed my return flight to extend my stay. I can recommend this program without reservation.\"<\/p>\n

The 10 medtech start-ups of 2025<\/h3>\n

This year's national start-up team in the medtech sector is made up as follows:<\/p>\n